推荐产品
产品名称
顺铂, Cisplatin - CAS 15663-27-1, is a platinum coordination complex with potent anti-neoplastic activity. Induces apoptosis in cancer cells, possibly via caspase-3 activation.
品質等級
描述
Merck USA index - 14, 2317
化驗
≥98% (HPLC)
形狀
solid
製造商／商標名
Calbiochem®
儲存條件
OK to freeze
顏色
yellow
溶解度
PBS with 140 mM NaCl: 1 mg/mL
water with 154 mM NaCl: 1 mg/mL
DMSO: 10 mg/mL
運輸包裝
ambient
一般說明
具有强效抗肿瘤活性的铂配位复合物。诱导癌细胞中的凋亡，可能通过caspase-3激活。据报道可使胶质瘤细胞对TNF-α-诱导的凋亡敏感。
注意：尽管顺铂在DMSO中高度可溶，但据报道由于配体被DMSO的亲核硫取代而变得无活性。建议在培养处理之前将氯化钠水溶液（154 mM NaCl，含或不含10 mg/mL甘露醇）或PBS（含140 mM NaCl）溶解。
注意：尽管顺铂在DMSO中高度可溶，但据报道由于配体被DMSO的亲核硫取代而变得无活性。建议在培养处理之前将氯化钠水溶液（154 mM NaCl，含或不含10 mg/mL甘露醇）或PBS（含140 mM NaCl）溶解。
生化／生理作用
主要靶标
诱导癌细胞凋亡
诱导癌细胞凋亡
产物不与ATP竞争。
可逆：否
细胞渗透性：否
警告
毒性：有毒 & 致癌/致畸性（G）
重構
溶液中不稳定；仅在使用前进行复溶。
其他說明
Hall, M.D., et al. 2014.Cancer Res. In press.
Duan, L., et al. 2001.J. Neurooncol.52, 23.
Mese, H., et al. 2000.Cancer Chemother.Pharmacol.46, 241.
Von Hoff, D.D., and Rozencweig, M. 1979. in Adv.Pharmacol.Chemother.16, 279.
Duan, L., et al. 2001.J. Neurooncol.52, 23.
Mese, H., et al. 2000.Cancer Chemother.Pharmacol.46, 241.
Von Hoff, D.D., and Rozencweig, M. 1979. in Adv.Pharmacol.Chemother.16, 279.
由于该运输中有害物质的性质，您的订单可能需要支付额外的运输费用。某些尺寸的产品可免除其他有害材料的运输费用。请与您当地的销售办事处联系，以获取有关这些费用的更多信息。
法律資訊
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
訊號詞
Danger
危險分類
Acute Tox. 2 Oral - Carc. 1B - Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3
標靶器官
Respiratory system
儲存類別代碼
6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials
水污染物質分類（WGK）
WGK 3
閃點（°F）
Not applicable
閃點（°C）
Not applicable
其他客户在看
Jinan Li et al.
Frontiers in molecular neuroscience, 15, 835448-835448 (2022-03-01)
Cisplatin is one of the most widely used chemotherapeutic drugs across the world. However, the serious ototoxic effects, leading to permanent hair cell death and hearing loss, significantly limit the utility of cisplatin. In zebrafish, the functional mechanotransduction channel is
Benjamin P Sharpe et al.
Cell reports. Medicine, 3(6), 100541-100541 (2022-06-23)
The chemotherapy resistance of esophageal adenocarcinomas (EACs) is underpinned by cancer cell extrinsic mechanisms of the tumor microenvironment (TME). We demonstrate that, by targeting the tumor-promoting functions of the predominant TME cell type, cancer-associated fibroblasts (CAFs) with phosphodiesterase type 5
Jiaqi Liu et al.
eLife, 10 (2021-12-18)
Gliomas are highly malignant brain tumors with poor prognosis and short survival. NAD+ has been shown to impact multiple processes that are dysregulated in cancer; however, anti-cancer therapies targeting NAD+ synthesis have had limited success due to insufficient mechanistic understanding.
Mohammed Hafiz Uddin et al.
Frontiers in oncology, 12, 908603-908603 (2022-07-19)
Poly (ADP-ribose) polymerase (PARP) inhibitors (PARPis) are currently being used for treating breast cancer patients with deleterious or suspected deleterious germline BRCA-mutated, HER2-negative locally advanced or metastatic diseases. Despite durable responses, almost all patients receiving PARPis ultimately develop resistance and
Hyang Sook Seol et al.
Journal of gynecologic oncology (2023-01-21)
Advanced cervical cancer is still difficult to treat and in the case of recurrent cancer, it is desirable to utilize personalized treatment rather than uniform treatment because the type of recurrence is different for each individual. Therefore, this study aimed
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门